Posted on April 6, 2011, 6 a.m. in
A major milestone in microfluidics could soon lead to stand-alone, self-powered chips that can diagnose diseases within minutes. The device, developed by an international team of researchers from the University of California, Berkeley, Dublin City University in Ireland and Universidad de Valparaíso Chile, is able to process whole blood samples without the use of external tubing and extra components. The researchers have dubbed the device SIMBAS, which stands for Self-powered Integrated Microfluidic Blood Analysis System.
Ivan K. Dimov, Lourdes Basabe-Desmonts, Jose L. Garcia-Cordero, Benjamin M. Ross, Antonio J. Ricco, Luke P. Lee. “Stand-alone self-powered integrated microfluidic blood analysis system (SIMBAS).” Lab Chip, 2011, 11, 845-850.
Health Headlines MORE »
Tetrahydrocannabinol (THC) may protect immune tissue in the gut from HIV infection damage.
The price of childhood obesity may be cancer, cardiovascular disease, type-2 diabetes, and other diseases later in life.
Daily supplementation of glucosamine with chondroitin reduces joint space narrowing.
Transcranial Doppler identifies a patent foramen ovale (PFO), which is an under-recognized cause of stroke.
Consumption of green tea (Camellia sinensis) helps to manage blood pressure and cholesterol levels.
Chronic stress may cause physiological changes to the brain that may make people prone to anxiety and mood disorders, later in life.
Irisin, a hormone released from muscle after exercise, correlates to telomere length.
Women who take aspirin daily may reduce the risk of ovarian cancer by 20%.
Dietary supplementation of omega-3 fatty acids may beneficially affect a dysfunction in the inflammatory response pathway.
Differing in specific brain structures, men and women may experience different neurological and psychological conditions.